Efficacy of an Assisted Therapy Optimizing Module to Improve Physician Adherence

NARecruitingINTERVENTIONAL
Enrollment

234

Participants

Timeline

Start Date

December 3, 2024

Primary Completion Date

September 30, 2027

Study Completion Date

September 30, 2027

Conditions
Heart Failure
Interventions
DEVICE

KITGuideMe: W61-MD41-AIT, version 1.0.0

"We are planning to conduct a prospective, 1:1 randomized study within the HM program.~Randomization occurs at the level of network physicians. Network physicians participating in the study are randomly assigned to either the AMPEL group (access to the module) or the non-AMPEL group (no access to the module) using a permuted block randomization scheme to ensure that there are the same number of patients in each study arm. Logical checks within the module ensure that once a network physician is assigned to an arm, he or she remains in that arm for the remainder of the stud"

Trial Locations (2)

6020

RECRUITING

Medical University of Innsbruck, University Hospital for Internal Medicine III (Cardiology and Angiology), Innsbruck

8036

RECRUITING

Medical University of Graz, University Hospital for Internal Medicine (Cardiology), Graz

All Listed Sponsors
collaborator

AIT Austrian Institute of Technology GmbH

OTHER

lead

Medical University Innsbruck

OTHER